MMP11 and CD2 as novel prognostic factors in hormone receptor-negative, HER2-positive breast cancer

PURPOSE: More accurate prediction of patient outcome based on molecular subtype is required to identify patients who will benefit from specific treatments. METHODS: We selected novel 16 candidate prognostic genes, including 10 proliferation-related genes (p-genes) and 6 immune response-related genes...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Breast Cancer Res Treat
Egile Nagusiak: Han, Jinil, Choi, Yoon-La, Kim, Haein, Choi, Jun Young, Lee, Se Kyung, Lee, Jeong Eon, Choi, Joon-Seok, Park, Sarah, Choi, Jong-Sun, Kim, Young Deug, Nam, Seok Jin, Nam, Byung-Ho, Kwon, Mi Jeong, Shin, Young Kee
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer US 2017
Gaiak:
Preclinical Study
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5487710/
https://ncbi.nlm.nih.gov/pubmed/28409241
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-017-4234-4
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak